Patient 1 | Patient 2 | Patient 3 | Patient 4 | |||||
---|---|---|---|---|---|---|---|---|
MII and/or pH monitoring during treatment with prucalopride | Medication during monitoring: | Medication during monitoring: | Medication during monitoring: | Medication during monitoring: | ||||
- Pantoprazole 40mg per day | - Pantoprazole 40mg per day | - Omeprazole 20mg per day | - Prucalopride 2mg per day | |||||
+ Prucalopride 2mg per day | + Prucalopride 2mg per day | + Prucalopride 2mg per day | ||||||
Acid reflux time: | 0.1% | Acid reflux time: | 0.9% | Acid reflux time: | 1.2% | Acid reflux time: | 1.9% | |
Overall reflux episodes: | 46 | Overall reflux episodes: | 108 | Overall reflux episodes: | 83 | Overall reflux episodes: | 59 | |
Mixed or liquid reflux episodes: | 5 | Mixed or liquid reflux episodes: | 100 | Mixed or liquid reflux episodes: | 74 | Mixed or liquid reflux episodes: | 40 | |
Gaseous reflux episodes: | 41 | Gaseous reflux episodes: | 8 | Gaseous reflux episodes: | 9 | Gaseous reflux episodes: | 19 | |
Acid reflux episodes: | 17 | Acid reflux episodes: | 32 | Acid reflux episodes: | 26 | 39 | ||
Non- and/or weakly acid reflux episodes: | 29 | Non- and/or weakly acid reflux episodes: | 76 | Non- and/or weakly acid reflux episodes: | 57 | Acid reflux episodes: Non- and/or weakly acid reflux episodes: | 20 | |
*Scale 0 to10: 0 = none; 10 = unbearable | Subjective symptom scores* | Subjective symptom scores* | Subjective symptom scores* | Subjective symptom scores* | ||||
- Heartburn + Regurgitation: 3 | - Heartburn + Regurgitation: 5 | - Regurgitation: 3 | - Heartburn, Globus, Bloating: 4 | |||||
Limitation of daily life: 3 | Limitation of daily life: 5 | Limitation of daily life: 3 | Limitation of daily life: 9 | |||||
SI: positive for heartburn and regurgitation | SI: positive for heartburn, negative for regurgitation | SI: negative for regurgitation | SI: negative for heartburn, globus and bloating |